Category: Research

Laboratory experiments show that a synthetic chemical is able to shut off glioblastoma cells’ energy source, leading to cell death

Our Research Communications Assistant, Arshiya, gives an overview of the International Symposium on Paediatric Neuro-Oncology (ISPNO)

Researchers from the Institute of Cancer Research discovered that tumour cells in paediatric high-grade gliomas work together to invade other structures of the brain

Results from a phase 1 clinical trial show that patients with recurrent glioblastoma treated with an inactive version of the polio virus live longer than those receiving standard treatment

New data presented at the recent American Association of Clinical Oncology (ASCO) meeting in Chicago by Abbvie, a pharmaceutical company, provides hope for those diagnosed with a glioblastoma

The research engagement team recently visited The Blizard Institute of Cell and Molecular Science in London and met with Dr Tom Millner

A study led by researchers from Duke Cancer Institute identifies genetic markers to classify previously undetermined glioblastomas

Early findings from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma.

Recent clinical data reports that a new surgical approach could improve survival for individuals with difficult to access high-grade gliomas

The new bank, announced today, will support and accelerate new research into brain cancer therapy

Researchers have identified a difference between low-grade and high-grade brain tumours that could help develop better treatments for more aggressive forms of the disease.

Results from a phase 1 clinical trial of the oncolytic virus DNX-2401, report successful intratumoral delivery of the virus in children with diffuse midline glioma

A research team of engineers and physicians at Washington University have developed a way to identify brain tumour biomarkers through a blood test

We are delighted to announce that we have joined forces with Cancer Research UK to create an unprecedented £18m fund for research into all aspects of brain tumours

Are you aged 16-17, in full time education, and would like to gain experience working in a laboratory focusing on research into brain tumours? Do you know someone who is?

Recently published research shows that CAR-T cell therapy, a type of immunotherapy, has the ability to treat diffuse midline glioma

Recent research has demonstrated that combination therapy to target a specific protein, called MYC, in tumour cells could prove to be effective in treating medulloblastoma

A recent study discovered that a protein, called FOXM1, is responsible for clinically aggressive meningiomas

Recent research has uncovered a metabolic pathway that could be involved in tumour survival and growth

Research funded by The Brain Tumour Charity has led to the development of a classification system for brain tumours based on molecular profiling

Last week we convened a panel of internationally renowned experts in the field, for our ‘Ask the Researcher: Panel Edition’ event at Kings College London

Results from a phase 1 clinical trial, testing a drug called CLR 124, demonstrates its ability to cross the blood-brain barrier

Researchers design immune cells to target a protein found on two thirds of glioblastomas, the most common and lethal primary brain tumour

A European research collaboration is developing a new “laboratory on a chip” device that will be able to rapidly detect the different types of cancer stem cells involved in two of the most aggressive brain tumours